Videos on COVID-19

Is mRNA technology something completely new? How does it work and how is it used in developing vaccines for infectious diseases?

How was it possible to develop COVID-19 vaccines so quickly? Watch our animation to learn more about their production.

Statement by ECDC Director, Dr Andrea Ammon, on the fourth dose of the mRNA COVID-19 vaccine.

A webinar on Multisystem Inflammatory Syndrome in Children (MIS-C) was jointly organised by the European Centre for Disease Prevention and Control (ECDC) and the European Society of Paediatric Infectious Diseases (ESPID) on 20 January 2022.

Statement by ECDC Director, Dr Andrea Ammon, on the situation in the EU/EEA regarding the Omicron variant of concern.

Statement by ECDC Director, Dr Andrea Ammon, on the COVID-19 situation in the EU/EEA ahead of the holiday season.

ECDC and the European Society of Paediatric Infectious Diseases (ESPID) organised a joint webinar on post-COVID-19 condition in children that took place on 10 November 2021.

Modelling scenarios indicate that the potential burden of disease in the EU/EEA from the Delta variant will be very high in December and January.

John Kinsman, expert on behaviour change, explains the key points of ECDC's report on facilitating COVID-19 vaccination acceptance and uptake in the EU/EEA, published on 15 October 2021.

ECDC Expert - Pasi Penttinen explains the most important messages from the ECDC Rapid Risk Assessment on COVID-19 in long-term care facilities, published on 26 July 2021.